Helge Lubenow

Helge Lubenow is an accomplished executive with extensive experience in the biotechnology sector. Currently serving as Vice Chair and Chairwoman of the Board of Directors at Biofrontera Group, Lubenow is also the Chief Executive Officer of Heidelberg Epignostix and holds significant positions at Epigenomics AG, Avelo, and NeraCare. Additionally, Lubenow has previously led Proteomedix AG as Chief Executive Officer and has contributed to various boards, including Human Gesellschaft für Biochemica und Diagnostika and evorion biotechnologies GmbH. With a PhD in Genetics from the University of Cologne and a degree in Biology from Justus Liebig University Giessen, Lubenow combines a robust educational background with a strong leadership presence in multiple organizations.